[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338545-105":59,"doc-detail-338545-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","mirnas-function-in-the-development-of-resistance-against-doxorubicin-in-cancer-cells-targeting-abc-transporters","MiRNAs function in the development of resistance against doxorubicin in cancer cells - targeting ABC transporters","","Resistance to chemotherapeutic agents remains a major obstacle in cancer care, especially for doxorubicin, widely used across breast cancer, leukemia, osteosarcoma, and gastrointestinal malignancies. This review explains how microRNAs (miRNAs) contribute to doxorubicin resistance by regulating ATP-binding cassette (ABC) transporters. It highlights a key knowledge gap: insufficient comprehensive understanding of how specific miRNAs modulate ABC transporter expression and activity. By synthesizing current studies, it evaluates therapeutic strategies that harness miRNA modulation to overcome resistance and improve doxorubicin efficacy.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/mirnas-function-in-the-development-of-resistance-against-doxorubicin-in-cancer-cells-targeting-abc-transporters/338545/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/mirnas-function-in-the-development-of-resistance-against-doxorubicin-in-cancer-cells-targeting-abc-transporters/338545.png","ImageObject",300,407,{"name":92,"@type":93},"Clementine","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-11","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of this review?","Question",{"text":112,"@type":113},"The review focuses on how microRNAs (miRNAs) drive resistance to doxorubicin in cancer cells, especially through interactions with ATP-binding cassette (ABC) transporters.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Why is doxorubicin resistance a serious problem in cancer treatment?",{"text":117,"@type":113},"Doxorubicin’s effectiveness is frequently reduced by the development of drug resistance, which undermines successful treatment outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"Which mechanism is emphasized as a key driver of doxorubicin resistance?",{"text":121,"@type":113},"Overexpression of ABC transporters, which actively expel chemotherapeutic agents like doxorubicin from cancer cells, is highlighted as a significant mechanism.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338545,1790189141,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","TYPE Review  \nPUBLISHED 29 November 2024 DOI 10.3389/fphar.2024.1486783  \nOPEN ACCESS  \nEDITED BY  \nXuelin Zhou,  \nCapital Medical University, China  \nREVIEWED BY  \nXiaodong Zou,  \nThe Chinese University of Hong Kong, Shenzhen, China  \nBei Zhang,  \nSouthern Methodist University, United States Guan Huang,  \nHarvard Medical School, United States Xiang Yu,  \nRutgers, The State University of New Jersey, United States  \nTing Wu,  \nBoston Children ’s Hospital and Harvard Medical School, United States  \nYusheng Li,  \nUniversity of Mississippi, United States  \n*CORRESPONDENCE  \nHongxu Jin,  \n [jinhongxu128@gmail.com](jinhongxu128@gmail.com)  \nRECEIVED 26 August 2024  \nACCEPTED 23 October 2024  \nPUBLISHED 29 November 2024  \nCITATION  \nLu X-Y and Jin H (2024) MiRNAs function in the development of resistance against doxorubicinin cancer cells: targeting ABC transporters.  \nFront. Pharmacol. 15:1486783 .  \ndoi: 10.3389/fphar.2024.1486783  \nCOPYRIGHT  \n© 2024 Lu and Jin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) . The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.  \nMiRNAs function in the development of resistance against doxorubicin in cancer cells: targeting ABC transporters  \nXin-Yan Lu 1 and Hongxu Jin 2*  \n1Department of General Surgery, Shengjing Hospital of China Medical University, Shenyang, China, 2Emergency Medicine Department of General Hospital of Northern Theater Command, Shenyang, Liaoning, China  \nResistance to chemotherapeutic agents poses a signiﬁcant challenge in cancer treatment, particularly with doxorubicin, a widely used drug for various cancers, including breast cancer, leukaemia, osteosarcoma, and gastrointestinal cancers. This review aims to elucidate the critical role of microRNAs (miRNAs) in the development of doxorubicin resistance, focusing on their interactions with ATPbinding cassette (ABC) transporters. Despite extensive research, the molecular mechanisms governing doxorubicin resistance still need to be completed, particularly regarding the regulatory inﬂuence of miRNAs on ABC transporter expression. By analyzing current literature, this review identiﬁes a notable gap: the lack of comprehensive insight into how speciﬁc miRNAs modulate the expression and activity of ABC transporters in cancer cells, contributing to doxorubicin resistance. We systematically examine recent ﬁndings on the interplay between miRNAs and ABC transporters, providing a detailed assessment of potential therapeutic strategies that leverage miRNA modulation to overcome drug resistance. Ultimately, this review underscores the signiﬁcance of integrating miRNA research into existing therapeutic frameworks to enhance the efﬁcacy of doxorubicin in cancer treatment.  \nKEYWORDS  \ndoxorubicin, ncRNA, miRNA-microRNA, chemoresisitance, ABC transporter  \n1 Introduction  \nCancer, as the second leading reason for death around the world, is known to impose a great burden on the socioeconomic situations of every country, which is a reason for increasing the attention of different countries to the topic of cancer and increasing investment in providing suitable solutions to prevent and treat this deadly disease (Siegel et al., 2023) . The past 20 years have witnessed the identiﬁcation and development of more than 70 targeted therapeutic agents as novel drugs for treating abroad range of cancer types (Kroemer et al., 2023) . These drugs combat cancers via inﬂuencing the proliferation, growth, survival, and metastasis of tumour cells, which is achieved by interfering with particular signalling pathways (Goossens and Bailly, 2019; Jairajpuri et al., 2024; Zhang et al., 2022) . However, narrow indications hav","cbCaimkMRILqZLsG","https://ap.wps.com/l/cbCaimkMRILqZLsG","pdf",3165225,26,"English","# 1 Introduction\n## Cancer burden and targeted therapy limitations\n## Conventional chemotherapy: resistance and adverse effects\n## Doxorubicin resistance and ABC transporters","[{\"question\":\"What is the main focus of this review?\",\"answer\":\"The review focuses on how microRNAs (miRNAs) drive resistance to doxorubicin in cancer cells, especially through interactions with ATP-binding cassette (ABC) transporters.\"},{\"question\":\"Why is doxorubicin resistance a serious problem in cancer treatment?\",\"answer\":\"Doxorubicin’s effectiveness is frequently reduced by the development of drug resistance, which undermines successful treatment outcomes.\"},{\"question\":\"Which mechanism is emphasized as a key driver of doxorubicin resistance?\",\"answer\":\"Overexpression of ABC transporters, which actively expel chemotherapeutic agents like doxorubicin from cancer cells, is highlighted as a significant mechanism.\"}]","MiRNAs function in the development of resistance against doxorubicin in cancer cells - targeting ABC transporters | PDF",1790024133,66,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/400875713da6888097d00346f50a81ef.webp",983,1390,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08d26987900907ef203ad8657f84569f.webp",982,1388,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d7f4067af20f49278caab1808700af66.webp",981,1387,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/741135dc021fb4c46cfc6cd3a38e2f97.webp",980,1385]